Amazon Pharmacy has expanded access to the new Zepbound KwikPen, a multi-dose injectable treatment for weight management ...

The 4-dose KwikPen device supports weight reduction in patients with obesity or overweight with weight-related conditions.

Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi ...

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units/mL, a pre-filled device containing Humulin ...

Eli Lilly announced the launch of Humulin R U-500 KwikPen (insulin human injection), a prefilled device containing a highly concentrated formulation of insulin. Eli Lilly announced the launch of ...

Used by millions of patients worldwide, the KwikPen® for single-patient use provides patients with a new option to receive Zepbound® Zepbound patients can access all doses in either multi-dose KwikPen ...

Please provide your email address to receive an email when new articles are posted on . The Zepbound KwikPen allows patients to receive four doses of the drug in a single pen device. According to Eli ...

Humulin R (insulin human) is a prescription drug that’s used to help manage high blood sugar levels caused by diabetes. Humulin R is given as an injection under the skin. Doctors prescribe Humulin R ...

Please provide your email address to receive an email when new articles are posted on . The European Medicine Agency’s Committee for Medicinal Products for Human Use recommended approval of Eli Lilly ...

The FDA-approved Zepbound KwikPen delivers a full month of treatment in one device and will be available to self-pay patients through LillyDirect starting Feb. 23.